APA

Laali E., Fazli J., Sadighi S., Mohammadi M., Gholami K. & Jahangard-Rafsanjani Z. (20200623). Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Chicago

Laali Elahe, Fazli Jinous, Sadighi Sanambar, Mohammadi Mehdi, Gholami Kheirollah and Jahangard-Rafsanjani Zahra. 20200623. Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Harvard

Laali E., Fazli J., Sadighi S., Mohammadi M., Gholami K. and Jahangard-Rafsanjani Z. (20200623). Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

MLA

Laali Elahe, Fazli Jinous, Sadighi Sanambar, Mohammadi Mehdi, Gholami Kheirollah and Jahangard-Rafsanjani Zahra. Appropriateness of using granulocyte colony-stimulating factor (G-CSF) for primary prophylaxis of febrile neutropenia in solid tumors. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20200623.